Skip to main content
$327.27 $1.65 (0.5%)

04:00 PM EDT on 06/27/22

Eli Lilly & Co. (NYSE:LLY)

CAPS Rating: 3 out of 5

The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.

Current Price $327.27 Mkt Cap $293.1B
Open $324.23 P/E Ratio 48.11
Prev. Close $327.27 Div. (Yield) $3.92 (1.2%)
Daily Range $322.00 - $330.85 Volume 3,218,824
52-Wk Range $220.20 - $330.85 Avg. Daily Vol. 3,246,199

Caps

How do you think NYSE:LLY will perform against the market?

Add Stock to CAPS Watchlist

All Players

1,236 Outperform
101 Underperform
 

All-Star Players

319 Outperform
14 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSE:LLY Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Teacherman333 (86.46)
Submitted June 01, 2013

For reference point and to allow for comments by others. As of the end of March, 2013.ROE 31.07%Trailing PE 12.78PB 3.92Div yield 3.60%

einzling44 (< 20)
Submitted May 15, 2012

cap spending ahead

Recent Community Commentary

Read the most recent pitches from players about LLY.

Recs

0
Member Avatar mrbill6 (59.49) Submitted: 6/16/2022 2:42:46 PM : Outperform Start Price: $285.28 NYSE:LLY Score: +8.28

A stock that will beat the doomsday crash

Recs

0
Member Avatar BrentonKJ (< 20) Submitted: 12/21/2021 10:27:17 AM : Outperform Start Price: $252.23 NYSE:LLY Score: +47.33

Best pharma pipeline

Recs

0
Member Avatar TMFkodyk123 (69.82) Submitted: 8/21/2021 4:30:49 PM : Outperform Start Price: $270.26 NYSE:LLY Score: +33.79

Eli Lilly's top-notch diabetes drug portfolio led by Trulicity, as well as its plaque psoriasis and psoriatic arthritis blockbuster Taltz should lead to mid-teen annual earnings growth in the foreseeable future. While Eli Lilly isn't a bargain buy at 34 times this year's earnings forecast, its growth prospects make up for its price.

Leaderboard

Find the members with the highest scoring picks in LLY.

Score Leader

thomasgb

thomasgb (34.01) Score: +1,238.27

The Score Leader is the player with the highest score across all their picks in LLY.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
thomasgb 34.01 3/4/2009 Outperform 3Y $18.25 +1,692.86% +454.59% +1,238.27 0 Comment
MarketPwnage 79.15 3/9/2009 Outperform NS $18.10 +1,708.42% +481.86% +1,226.56 0 Comment
tektan 93.25 3/9/2009 Outperform 5Y $18.10 +1,708.42% +481.86% +1,226.56 0 Comment
MCMInvest 69.19 3/9/2009 Outperform NS $18.10 +1,708.42% +481.86% +1,226.56 0 Comment
harryhotspur1403 69.70 10/10/2008 10/14/2011 Outperform 1Y $19.48 +1,580.07% +359.26% +1,220.80 0 Comment
LordCoolio 68.62 3/2/2009 Outperform 3M $18.63 +1,656.45% +445.41% +1,211.04 0 Comment
fredericch 96.37 3/2/2009 Outperform NS $18.63 +1,656.45% +445.41% +1,211.04 0 Comment
eyeseeu2 97.72 11/21/2008 Outperform NS $19.01 +1,621.23% +414.81% +1,206.43 0 Comment
srdreyer 73.44 10/28/2008 Outperform 1Y $19.61 +1,569.18% +362.93% +1,206.26 0 Comment
juliehowe 65.53 10/28/2008 Outperform 1Y $19.73 +1,558.41% +354.07% +1,204.34 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for LLY.